why choose us

First received: October 18, 2022

Clinical Trial: Preoperative Stereotactic Body Radiotherapy (SBRT) Followed by Hepatectomy for Centrally Located Hepatocellular Carcinoma: a Prospective, Single-center, Phase I Study

Study Status: Completed

Recruit Status: RECRUITING

Condition: Centrally Located Hepatocellular Carcinoma

Study Type: INTERVENTIONAL


Official Title: Preoperative Stereotactic Body Radiotherapy (SBRT) Followed by Hepatectomy for Centrally Located Hepatocellular Carcinoma: a Prospective, Single-center, Phase I Study

Brief Summary: Hepatocellular carcinoma (HCC) is the sixth prevalent malignancy worldwide.Although surgical excision is considered the standard treatment for resectable HCC, a high rate of postoperative recurrence was observed after partial hepatectomy, with a marginal recurrence rate up to 30%.Narrow margin resection may be the most appropriate procedure for centrally located HCC because the premise for survival is the conservation of more normal liver parenchyma.Unfortunately, narrow margin resection has been reported to…

Read more